The birth of a child is one of the most wonderful moments in the life of every family. However, unfortunately, sometimes it happens that the joy of having a baby is overshadowed by illness. Fortunately, world medicine already knows how to treat many diseases, and biotechnology and stem cells have become an important tool for modern doctors in the fight against various diseases.
In 2020, it will be 15 years since the first use of umbilical cord blood stem cells in the treatment of cerebral palsy, performed by Professor Joan Kurtsberg at Duke University (USA). The first patient to receive experimental stem cell therapy to treat cerebral palsy was a girl named Abby, whose parents turned out to have preserved her umbilical cord blood at birth.
The world’s first use of umbilical cord blood in the treatment of cerebral palsy was made on February 15, 2005. Therapeutic infusion lasted 20 minutes.
Unfortunately, the doctors were not able to completely overcome the girl’s illness, but 2 weeks after the introduction of the umbilical cord blood stem cells, the child began to fixate her eyes and follow the objects. And after 2 years, magnetic resonance imaging showed positive dynamics.
Abby is now 15 years old. She can move with the help of assistants, loves to ride, too, with the support of volunteers. The young patient and her parents are waiting for new opportunities in medicine and cell technologies.
During these 15 years, umbilical cord blood stem cells have been widely used in the treatment of cerebral palsy, ischemic-hypoxic brain damage, autism in clinical trials. The experience of treating neurological diseases in children with the help of stem cells is encouraging. And a valuable source of stem cells is umbilical cord blood, that is, the baby is already born with a supply of unique drugs given by nature.
Source: https://blog.cordblood.com/2019/11/how-one-mom-helped-launch-cord-blood-in-regenerative-medicine/ and the data of the Association of Cryobanks
The Ukraine’s first and only ISO-accredited cryobank, established in 2003 at the Institute of Cell Therapy, offers expectant parents to make a valuable investment in family health – to save at birth baby’s stem cells of the umbilical cord blood, placenta and umbilical cord, which are already used in the treatment of about 100 diseases. Cryopreservation technologies of biomaterial used by the Institute of Cell Therapy meet the best world standards.